Homology Medicines, Inc. Uncategorized Contracts & Agreements
18 Contracts & Agreements
- Contingent Value Rights Agreement dated March 23, 2024, by and between Homology Medicines Inc. and Equiniti Trust Company, LLC (Filed With SEC on March 27, 2024)
- Form of Lock-Up Agreement (Filed With SEC on March 27, 2024)
- Description of Securities (Filed With SEC on March 13, 2024)
- Form of Support Agreement by and between Q32 Bio Inc. and certain stockholders of Homology Medicines, Inc (Filed With SEC on December 18, 2023)
- Form of CVR Agreement (Filed With SEC on December 18, 2023)
- Form of Support Agreement by and between Homology Medicines, Inc. and certain stockholders of Q32 Bio Inc (Filed With SEC on December 18, 2023)
- Form of CVR Agreement (Filed With SEC on November 16, 2023)
- Form of Lock-Up Agreement by and between Q32 Bio Inc. and certain directors of Homology Medicines, Inc (Filed With SEC on November 16, 2023)
- Form of Lock-Up Agreement by and between Q32 Bio Inc. and directors, officers and certain stockholders of Q32 Bio Inc (Filed With SEC on November 16, 2023)
- Form of Support Agreement by and between Q32 Bio Inc. and certain stockholders of Homology Medicines, Inc (Filed With SEC on November 16, 2023)
- Form of Support Agreement by and between Homology Medicines, Inc. and certain stockholders of Q32 Bio Inc (Filed With SEC on November 16, 2023)
- Description of Securities (Filed With SEC on March 11, 2021)
- Description of Securities (Filed With SEC on March 12, 2020)
- Offer Letter to Arthur O. Tzianabos, dated March 31, 2016 (Filed With SEC on March 19, 2018)
- Letter Agreement, dated November 14, 2017, between the Registrant and California Institute of Technology (Filed With SEC on March 2, 2018)
- Offer Letter to Arthur O. Tzianabos, dated March 31, 2016 (Filed With SEC on March 2, 2018)
- Offer Letter to Albert Seymour, dated February 14, 2016 (Filed With SEC on March 2, 2018)
- Offer Letter to Siyamak (Sam) Rasty, dated December 7, 2015 (Filed With SEC on March 2, 2018)
